Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study

Leuk Lymphoma. 2022 Apr;63(4):834-844. doi: 10.1080/10428194.2021.2010060. Epub 2022 Jan 25.

Abstract

Few data exist concerning circulating tumor DNA (ctDNA) relevance in primary mediastinal B-cell lymphoma (PMBL). To explore this topic, we applied a 9-gene next-generation sequencing pipeline to samples from forty-four PMBL patients (median age 36.5 years). The primary endpoint was a similarity between paired biopsy/plasma mutational profiles. We detected at least one variant in 32 plasma samples (80%). The similarity between the biopsy and ctDNA genetic profiles for the 30 patients with paired mutated biopsy/plasma samples was greater than or equal to 80% in 19 patients (63.3%). We then compared PMBL ctDNA features with those of a cohort of Hodgkin lymphoma patients (n = 60). The top three mutated genes were SOCS1, TNFAIP3, and B2M in both lymphoma types. PMBL displayed more alterations in TNFAIP3 (71.9% vs. 46.3%, p = 0.029) and GNA13 (46.9% vs. 17.1%, p = 0.013) than cHL. Our 9-gene set may delineate tumor genotypes using ctDNA samples from both lymphoma types.

Keywords: Primary mediastinal large B cell lymphoma; cell-free DNA; circulating tumor DNA; classical Hodgkin lymphoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Circulating Tumor DNA* / genetics
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / genetics
  • Hodgkin Disease* / pathology
  • Humans
  • Lymphoma, B-Cell* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Mediastinal Neoplasms* / diagnosis
  • Mediastinal Neoplasms* / genetics
  • Mediastinal Neoplasms* / pathology
  • Retrospective Studies

Substances

  • Circulating Tumor DNA